Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection1
暂无分享,去创建一个
Warwick J. Britton | Jonathon D. Sedgwick | Helen Briscoe | Bernadette M. Saunders | Stephen Tran | Sigrid Ruuls
[1] S. Kaufmann,et al. Confrontation between intracellular bacteria and the immune system. , 1999, Advances in immunology.
[2] D. Männel,et al. The TNFTNF Receptor System , 2002 .
[3] M. Nashleanas,et al. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. , 1999, Journal of immunology.
[4] J. Cyster,et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. , 2001, Immunity.
[5] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[6] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[7] Nurit Lichtenstein,et al. TNF-α Associated with Extracellular Matrix Fibronectin Provides a Stop Signal for Chemotactically Migrating T Cells1 , 2000, The Journal of Immunology.
[8] J. Gómez-Reino,et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. , 2003, Arthritis and rheumatism.
[9] Klaus Pfeffer,et al. Lethal Granuloma Disintegration in Mycobacteria-Infected TNFRp55−/− Mice Is Dependent on T Cells and IL-121 , 2000, The Journal of Immunology.
[10] David Wallach,et al. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’ , 1999, The EMBO journal.
[11] S. Franitza,et al. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix , 2001, Journal of leukocyte biology.
[12] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[13] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[14] B. Gicquel,et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. , 2004, The Journal of clinical investigation.
[15] Warwick J. Britton,et al. Secreted Lymphotoxin-α Is Essential for the Control of an Intracellular Bacterial Infection , 2001, The Journal of experimental medicine.
[16] D. Rathjen,et al. A Tumor Necrosis Factor Mimetic Peptide Activates a Murine Macrophage Cell Line To Inhibit Mycobacterial Growth in a Nitric Oxide-Dependent Fashion , 1998, Infection and Immunity.
[17] R S Wallis,et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] JoAnne L. Flynn,et al. Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.
[19] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[20] D. Liggitt,et al. Local Role for Tumor Necrosis Factor Alpha in the Pulmonary Inflammatory Response to Mycobacterium tuberculosis Infection , 2002, Infection and Immunity.
[21] D. Wendling,et al. The use of TNF-α blocking agents in rheumatoid arthritis: an overview , 2004, Expert opinion on pharmacotherapy.
[22] Xiao-Yu Song,et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists. , 2002, The Journal of pharmacology and experimental therapeutics.
[23] S. Kaufmann,et al. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor , 1990, Infection and immunity.
[24] Joseph Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .
[25] K. Pfeffer,et al. Fatal Granuloma Necrosis without Exacerbated Mycobacterial Growth in Tumor Necrosis Factor Receptor p55 Gene-Deficient Mice Intravenously Infected with Mycobacterium avium , 1999, Infection and Immunity.
[26] W. Lesslauer,et al. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN‐γ in the differentiation of protective granulomas , 1997, European journal of immunology.
[27] J. Naismith,et al. TNFα and the TNF receptor superfamily: Structure‐function relationship(s) , 2000, Microscopy research and technique.
[28] R. Kimberly,et al. Immunobiology of tumor necrosis factor receptor superfamily , 2002, Immunologic research.
[29] J. Kolls,et al. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. , 1995, The Journal of infectious diseases.
[30] R. Guler,et al. Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance to Mycobacterium bovis Bacillus Calmette-Guérin Infection in the Absence of Secreted TNF and Lymphotoxin-α1 , 2002, The Journal of Immunology.
[31] J. Sedgwick,et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.
[32] B. Ryffel,et al. Correction of Defective Host Response to Mycobacterium Bovis BCG Infection in TNF-Deficient Mice by Bone Marrow Transplantation , 2000, Laboratory Investigation.
[33] Andrew G. D. Bean,et al. TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.
[34] S. Kaufmann,et al. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: regulation by endogenous tumor necrosis factor-α and by IL-10 , 1994 .
[35] Walter Kolch,et al. Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1 , 2000, The Journal of Immunology.
[36] P. Kaye,et al. Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria , 2002, The Journal of experimental medicine.
[37] S. Ehlers,et al. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF , 2003, Annals of the rheumatic diseases.
[38] B. Dijkmans,et al. New therapeutic targets for rheumatoid arthritis , 1999, Pharmacy World and Science.
[39] K. Frei,et al. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. , 1999, The American journal of pathology.
[40] John Chan,et al. TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection1 , 2004, The Journal of Immunology.
[41] W. Britton,et al. T cell‐derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection , 2004, Clinical and experimental immunology.
[42] D. Männel,et al. The TNF-TNF receptor system. , 2002, Biological chemistry.
[43] A. Bean,et al. Increase in Gamma Interferon-Secreting CD8+, as Well as CD4+, T Cells in Lungs following Aerosol Infection with Mycobacterium tuberculosis , 1999, Infection and Immunity.
[44] S. Kaufmann,et al. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistance , 1995, European journal of immunology.
[45] J. Pollard,et al. Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting , 1997, The Journal of experimental medicine.
[46] C. Dinarello. Anti-cytokine therapeutics and infections. , 2003, Vaccine.
[47] M. McDermott. TNF and TNFR biology in health and disease. , 2001, Cellular and molecular biology.
[48] I. Orme,et al. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. , 2002, Cellular immunology.